Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.064 AUD | +6.67% | +4.92% | -20.00% |
Apr. 16 | Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing | MT |
Mar. 27 | Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II | MT |
Sales 2022 | 1.98M 1.29M | Sales 2023 | 1.19M 775K | Capitalization | 16.49M 10.75M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.96M | Net income 2023 | -6M -3.91M | EV / Sales 2022 | 7.87 x |
Net cash position 2022 | 12.51M 8.15M | Net cash position 2023 | 6.98M 4.55M | EV / Sales 2023 | 7.99 x |
P/E ratio 2022 |
-5.79
x | P/E ratio 2023 |
-2.64
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.95% |
1 day | +6.67% | ||
1 week | +4.92% | ||
Current month | -16.88% | ||
1 month | -16.88% | ||
3 months | -20.00% | ||
6 months | -21.95% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 00-05-30 | |
Tim Luscombe
DFI | Director of Finance/CFO | - | 23-09-24 |
Rhiannon Jones
COO | Chief Operating Officer | - | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Cooke
SEC | Corporate Secretary | 62 | 13-10-10 |
Robert Peach
BRD | Director/Board Member | 68 | 15-09-01 |
Warwick Tong
CHM | Chairman | - | 18-05-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.064 | +6.67% | 342,635 |
24-04-23 | 0.06 | -7.69% | 191,395 |
24-04-22 | 0.065 | +6.56% | 649 |
24-04-19 | 0.061 | 0.00% | 168,697 |
24-04-17 | 0.061 | -12.86% | 560,720 |
Delayed Quote Australian S.E., April 24, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-20.00% | 8.06M | |
-1.99% | 104B | |
+1.88% | 97.42B | |
+0.79% | 22.2B | |
-17.75% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.45% | 15.06B | |
+3.56% | 13.98B | |
+33.33% | 11.66B |
- Stock Market
- Equities
- ATX Stock